Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001628280-18-003885
Filing Date
2018-04-02
Accepted
2018-04-02 13:26:13
Documents
4
Effectiveness Date
2018-04-02

Document Format Files

Seq Description Document Type Size
1 DEFA14A formdefa14a40218.htm DEFA14A 24881
2 fibrocellnoticecard001.jpg GRAPHIC 65181
3 fibrocellnoticecard002.jpg GRAPHIC 116212
4 fibrocellnoticecard003.jpg GRAPHIC 35331
  Complete submission text file 0001628280-18-003885.txt   325135
Mailing Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341
Business Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341 484-713-6000
Fibrocell Science, Inc. (Filer) CIK: 0000357097 (see all company filings)

EIN.: 870458888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-31564 | Film No.: 18728117
SIC: 2834 Pharmaceutical Preparations